Acumen research and consulting estimates that the global sepsis diagnostics market is anticipated to reach market size of around US$ 800 Mn by 2027 and is anticipated to grow at a CAGR of around 9% in terms of revenue during the forecast period 2020 – 2027. Sepsis is a serious complication due to an impaired immune system that leads to bacterial, viral, fungal, parasitic or other infection. In hospitals, sepsis is a major cause of death. Sepsis occurs if the body's immune system responds to a disease and chemicals are released to treat the infection through the immune system. It also causes inflammation in the body when it enters the bloodstream. It leads to blood clots, blood vessel leakage, and poor blood flow, and oxygen and nutrients have been taken away from the vital bodies. Many physicians starting with sepsis and leading to severe sepsis, and ultimately to a septic shock, which is considered a medical emergency, are considered as a three-stage syndrome.
Market Insights
The growing prevalence of various antibiotic resistant bacterial strains, aging individuals, and increasing awareness of health and healthcare expenses is key to the growth of the global market for sepsis diagnosis. Moreover, the growth of the global sepsis diagnostics market will in the near future be driven by the increasing number of surgical procedures and by an increase in the number of product approvals. The major factor in the growth of the global sepsis diagnostics market is the high incidence of infected hospitals. According to Centers for Disease Control and Prevention (CDC), in the U.S. over 1.7 million adults suffer from sepsis every year, which leads to approximately 270,000 deaths. In addition, according to the 2018 Organization for Economic Co-operation and Development (OECD) report, approximately 3.8 million patients in acute care hospitals in European countries suffer from hospital-acquiring infections (HAIs) every year. The high prevalence of healthcare-associated infections (HAIs) in key regions is expected to increase medical testing solutions demand significantly and therefore fuel market growth during the forecast period.
In 2019, the microbiology segment accounts to hold large market share of global sepsis diagnostics market and is projected to grow the market during forecast period 2020-2027. It can be mentioned even though microbiology enables microorganisms through the use of media for blood culture to be quantitatively identified through blood culture testing. A profitable CAGR over the forecast period is expected to be seen in the molecular diagnosis segment. Due to its various benefits, such as high sensitivity, accuracy, and less turnaround time over other technologies, increasing use of molecular diagnostic technology will drive the growth of the segment. However, it is an inconvenience to this technique that uncultivable organisms are not identified. However, molecular diagnostic technique is regarded after blood cultivation as a normal pathogen identification technique.
Report coverage
The market research study on “Sepsis Diagnostics Market (By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry; By Product: Blood Culture Media, Instruments, Assays & Reagents; By Method: Conventional Diagnostics, Automated Diagnostics; By Usability: Laboratory Testing, Point-of-care Testing; By Pathogen: Bacterial Sepsis, Gram-negative Bacterial Sepsis, Gram-positive Bacterial Sepsis, Fungal Sepsis, Others) - Global Industry, Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers detailed insights on the global sepsis diagnostics market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report provides insights on global sepsis diagnostics market are technology, product, method, usability, pathogen and major geographic regions. The sepsis diagnostics market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
North America accounts to hold large market share of global sepsis diagnostics market in 2019 due to Due to factors such as increased demand of better health care facilities, increasing adoption of new and advanced diagnostic techniques, high per capita health expenditure and increased incidences of chronic diseases such as cancer, diabetes, and others. In terms of factors such as increasing geriatric population in the region combined with developing healthcare facilities and an increase in cancer and diabetes prevalence in countries like India , China and Australia, the Asia Pacific region is expected to be at their highest level during the forecast period 2020-2027. However, in Asia Pacific some factors restrict sepsis diagnostic market growth in this region are lacking awareness and skilled workers.
Key Players
Major players included in this report are Roche Diagnostics, Becton Dickinson Company, bioMérieux, Danaher, Bruker, Abbott Laboratories, T2 Biosystems, Luminex, Thermo Fisher Scientific, EKF Diagnostics, Response Biomedica, Immunexpress, Axis-Shield Diagnostics, CytoSorbents, and others.
The global sepsis diagnostics market is segmented as below:
Market Segmentation
Sepsis Diagnostics Market By Technology
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Sepsis Diagnostics Market By Product
Blood Culture Media
Instruments
Assays & Reagents
Sepsis Diagnostics Market By Usability
Laboratory Testing
Point-of-care Testing
Sepsis Diagnostics Market By Pathogen
Bacterial Sepsis
Gram-negative Bacterial Sepsis
Gram-positive Bacterial Sepsis
Fungal Sepsis
Others
Sepsis Diagnostics Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Sepsis Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Sepsis Diagnostics Market By Technology
1.2.2.1. Global Sepsis Diagnostics Market Revenue and Growth Rate Comparison By Technology (2020-2027)
1.2.2.2. Global Sepsis Diagnostics Market Revenue Share By Technology in 2019
1.2.2.3. Microbiology
1.2.2.4. Molecular Diagnostics
1.2.2.5. Immunoassays
1.2.2.6. Flow Cytometry
1.2.3. Sepsis Diagnostics Market By Product
1.2.3.1. Global Sepsis Diagnostics Market Revenue and Growth Rate Comparison By Product (2020-2027)
1.2.3.1.1. Blood Culture Media
1.2.3.1.2. Instruments
1.2.3.1.3. Assays & Reagents
1.2.4. Sepsis Diagnostics Market By Usability
1.2.4.1. Global Sepsis Diagnostics Market Revenue and Growth Rate Comparison By Usability (2020-2027)
1.2.4.2. Laboratory Testing
1.2.4.3. Point-of-care Testing
1.2.5. Sepsis Diagnostics Market By Pathogen
1.2.5.1. Global Sepsis Diagnostics Market Revenue and Growth Rate Comparison By Pathogen (2020-2027)
1.2.5.2. Bacterial Sepsis
1.2.5.3. Gram-negative Bacterial Sepsis
1.2.5.4. Gram-positive Bacterial Sepsis
1.2.5.5. Fungal Sepsis
1.2.5.6. Others
1.2.6. Sepsis Diagnostics Market By Geography
1.2.6.1. Global Sepsis Diagnostics Market Revenue and Growth Rate Comparison by Geography (2020-2027)
1.2.6.2. North America Sepsis Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.6.3. Europe Sepsis Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.6.4. Asia-Pacific Sepsis Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.6.5. Latin America Sepsis Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.6.6. Middle East and Africa (MEA) Sepsis Diagnostics Market Revenue and Growth Rate(2020-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Sepsis Diagnostics Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Sepsis Diagnostics Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Sepsis Diagnostics Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Sepsis Diagnostics Major Manufacturers in 2019
CHAPTER 4. Sepsis Diagnostics MARKET By Technology
4.1. Global Sepsis Diagnostics Revenue By Technology
4.2. Microbiology
4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. Molecular Diagnostics
4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.4. Immunoassays
4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.5. Flow Cytometry
4.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 5. Sepsis Diagnostics MARKET By Product
5.1. Global Sepsis Diagnostics Revenue By Product
5.2. Blood Culture Media
5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Instruments
5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.4. Assays & Reagents
5.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 6. Sepsis Diagnostics MARKET By Usability
6.1. Global Sepsis Diagnostics Revenue By Usability
6.2. Laboratory Testing
6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.3. Point-of-care Testing
6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 7. Sepsis Diagnostics MARKET By Pathogen
7.1. Global Sepsis Diagnostics Revenue By Pathogen
7.2. Bacterial Sepsis
7.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
7.3. Gram-negative Bacterial Sepsis
7.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
7.4. Gram-positive Bacterial Sepsis
7.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
7.5. Fungal Sepsis
7.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
7.6. Others
7.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 8. NORTH AMERICA Sepsis Diagnostics MARKET BY COUNTRY
8.1. North America Sepsis Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. North America Sepsis Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. U.S.
8.3.1. U.S. Sepsis Diagnostics Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
8.3.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
8.4.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
CHAPTER 9. EUROPE Sepsis Diagnostics MARKET BY COUNTRY
9.1. Europe Sepsis Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Europe Sepsis Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
9.3.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
9.4.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
9.5.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
9.6.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
9.7.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
CHAPTER 10. ASIA-PACIFIC Sepsis Diagnostics MARKET BY COUNTRY
10.1. Asia-Pacific Sepsis Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Asia-Pacific Sepsis Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
10.3.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
10.4.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
10.5.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
10.6.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.6.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
10.6.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
10.7.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.7.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
10.7.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
10.8.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.8.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
10.8.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
CHAPTER 11. LATIN AMERICA Sepsis Diagnostics MARKET BY COUNTRY
11.1. Latin America Sepsis Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Latin America Sepsis Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
11.3.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
11.4.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
11.5.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
CHAPTER 12. MIDDLE EAST & AFRICA Sepsis Diagnostics MARKET BY COUNTRY
12.1. Middle East & Africa Sepsis Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
12.2. Middle East & Africa Sepsis Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
12.3.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
12.3.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
12.3.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
12.4.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
12.4.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
12.4.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Technology, 2020 - 2027 ($Million)
12.5.2. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
12.5.3. Market Revenue and Forecast By Usability, 2020 - 2027 ($Million)
12.5.4. Market Revenue and Forecast By Pathogen, 2020 - 2027 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Roche Diagnostics
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Becton Dickinson Company
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. bioMérieux
3.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Danaher
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bruker
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Abbott Laboratories
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Biomatters Ltd.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.5. T2 Biosystems
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Luminex
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Thermo Fisher Scientific
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
